Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness.

COVID-19 homeless shelter vaccine hesitancy viral hepatitis vulnerable populations

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
May 2022
Historique:
received: 06 01 2022
accepted: 04 04 2022
entrez: 9 5 2022
pubmed: 10 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Vaccination for both hepatitis A (HAV) and hepatitis B (HBV) is recommended in hepatitis C infection (HCV). Among HCV antibody-positive persons experiencing homelessness, we identified high rates of HAV (34%) and HBV vaccine (35%) eligibility, highlighting critical gaps in HCV preventative services. Following education, 54% and 72% underwent HAV and HBV vaccination, respectively.

Identifiants

pubmed: 35531381
doi: 10.1093/ofid/ofac175
pii: ofac175
pmc: PMC9070334
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofac175

Subventions

Organisme : NIAAA NIH HHS
ID : K24 AA022523
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

Hepatol Commun. 2020 Mar 03;4(5):646-656
pubmed: 32363316
BMC Infect Dis. 2020 May 29;20(1):386
pubmed: 32471376
Clin Liver Dis. 2016 Nov;20(4):607-628
pubmed: 27742003
J Viral Hepat. 2018 Nov;25(11):1260-1269
pubmed: 29851232
Fam Community Health. 2020 Apr/Jun;43(2):161-169
pubmed: 32079972
Open Forum Infect Dis. 2022 Mar 01;9(4):ofac103
pubmed: 35369281
MMWR Morb Mortal Wkly Rep. 2018 Nov 02;67(43):1208-1210
pubmed: 30383739
Clin Liver Dis (Hoboken). 2021 Jun 04;17(5):365-370
pubmed: 34136143
J Med Virol. 2021 Jun;93(6):3991-3994
pubmed: 33448443
Lancet Public Health. 2021 May;6(5):e309-e323
pubmed: 33780656
Am J Public Health. 1997 Feb;87(2):217-20
pubmed: 9103100
Vaccine. 2021 Feb 22;39(8):1205-1224
pubmed: 33509694
Ann Intern Med. 2022 Mar;175(3):432-443
pubmed: 35175828
Public Health Rep. 2009 Nov-Dec;124(6):813-7
pubmed: 19894423
MMWR Recomm Rep. 2018 Jan 12;67(1):1-31
pubmed: 29939980
Public Health. 2001 Jul;115(4):286-91
pubmed: 11464302
Hepatology. 2020 Feb;71(2):686-721
pubmed: 31816111
F1000Res. 2019 Jan 14;8:
pubmed: 30687501
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403
pubmed: 29599078
Public Health Rep. 2020 Sep/Oct;135(5):691-699
pubmed: 32791034
MMWR Recomm Rep. 2020 Jul 03;69(5):1-38
pubmed: 32614811
Public Health. 2021 Oct;199:e2-e3
pubmed: 34548161
Heliyon. 2020 Mar 26;6(3):e03474
pubmed: 32258449
J Gen Intern Med. 2022 Mar;37(4):823-829
pubmed: 34704204
Hepatol Commun. 2022 Jan;6(1):50-64
pubmed: 34628726
JAMA Intern Med. 2018 Sep 1;178(9):1242-1248
pubmed: 30073282
Vaccine. 2018 Jan 29;36(5):668-674
pubmed: 29289383
Hepatology. 2018 Apr;67(4):1560-1599
pubmed: 29405329
BMC Infect Dis. 2019 May 2;19(1):372
pubmed: 31046683

Auteurs

Diana Partida (D)

Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Jesse Powell (J)

Hennepin Healthcare, Minneapolis, Minnesota, USA.

Daniel Gonzalez (D)

Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Mandana Khalili (M)

Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Classifications MeSH